Skip to content
Screener

NeoGenomics NEO Q2 2025 earnings

Reported July 29, 2025 · Before market open

Revenue$181.3MMiss by $2.5M
EPS$0.03In line
Revenue estimate$183.9M
EPS estimate$0.03

Next report

Oct 27, 2026 (in a month)
Revenue estimate$205.9M
EPS estimate$0.06

Financials

Q2 2025

Income statement

See full
Revenue$181.3M+10.2%
Gross profit$77.3M+6.6%
Operating income-$47.6M-117%
Net income-$45.1M-142%
EPS (diluted)-$0.35-133%

Balance sheet

See full
Cash & equivalents$154.7M-56.4%
Total debt$70.7M+5.7%
Total equity$854.0M-6.8%
Total assets$1.4B-15.2%

Cash flow

See full
Operating cash flow$20.3M—
CapEx$6.3M-51.7%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$930.46M-46.8%
Enterprise value$846.41M-42.1%
P/S1.4×-1.4×

Profitability

See full
Gross margin43.9%+1.3pp
Operating margin-16.7%+1.9pp
Net margin-15.1%+4.0pp

Returns & leverage

See full
Return on equity-11.8%+7.9pp
Debt / equity0.1×0.0×
Current ratio3.9×+1.9×

Segments

By product

See full
Client direct billing$131.2M+37.8%
Commercial insurance$28.8M+15.8%
Self-pay$20.0K-87.3%

By segment

See full
Reportable Segment$181.3M—

FAQ

When did NeoGenomics report Q2 2025 earnings?
NeoGenomics (NEO) reported Q2 2025 earnings on July 29, 2025 before market open.
What were NeoGenomics's Q2 2025 revenue and EPS?
NeoGenomics reported revenue of $181.3M and eps of $0.03 for Q2 2025.
Did NeoGenomics beat estimates in Q2 2025?
Revenue missed the consensus estimate of $183.9M by $2.5M. EPS beat the consensus estimate of $0.03 by $0.00.
How did NeoGenomics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.2% from $164.5M a year earlier and eps grew 0.0% from $0.03.
Where can I find NeoGenomics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001077183-25-000151) and the 10-Q periodic report (0001077183-25-000154) directly on SEC EDGAR. The filing index links above go to sec.gov.